News Archive
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”
.jpg "Fusion Antibodies - Landscape (Trimmed)")
.png "MyHealthChecked PLC_Logo_2 Line_Colour_Red_RGB_AW (003)"){kind=logo}
